Status:
UNKNOWN
Inhalation of KELEA Excellerated Water in Covid-19 Infected Individuals
Lead Sponsor:
Institute of Progressive Medicine
Conditions:
Covid19
Eligibility:
All Genders
Phase:
NA
Brief Summary
Preliminary reports have been received from several sources that the periodic inhaling of the nebulized mist from water that has a heightened level of kinetic activity has quickly (less than 2 days) l...
Detailed Description
Several producers of activated water have been in frequent communication with the Principal Investigator (PI) over the last decade or longer. They have regularly supplied their water products to the P...
Eligibility Criteria
Inclusion
- Individuals entering into quarantine because of a positive Covid-19 test using either PCR or an authorized antigen assay. It is not necessary, but preferable, for the participant to be symptomatic for Covid-19 -
Exclusion
- Unwilling to do repeat PCR and/or antigen testing or to provide the results of the repeat testing or the requested clinical data
- \-
Key Trial Info
Start Date :
October 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 30 2024
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04490824
Start Date
October 1 2020
End Date
March 30 2024
Last Update
October 4 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Progressive Medicine
South Pasadena, California, United States, 91030